DAX23.465 +1,0%Est505.574 +0,8%MSCI World4.343 -0,1%Top 10 Crypto12,19 -2,0%Nas23.026 +0,7%Bitcoin75.589 -1,3%Euro1,1571 +0,4%Öl62,64 -1,2%Gold4.132 -0,1%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 NVIDIA 918422 DroneShield A2DMAA Bayer BAY001 Alphabet A (ex Google) A14Y6F RENK RENK73 Novo Nordisk A3EU6F Lufthansa 823212 Siemens Energy ENER6Y Amazon 906866 Deutsche Telekom 555750 Tesla A1CX3T HENSOLDT HAG000 TKMS thyssenkrupp Marine Systems TKMS00 BASF BASF11
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Dow schließt deutlich stärker -- DAX letztlich fester -- Voting über CureVac-BioNTech-Fusion -- Zoom, D-Wave, Kohl's, Apple, Rheinmetall & Co., DroneShield, Tesla, Alibaba, Gold, AMD, TKMS im Fokus
Top News
Bitcoin-Wale schlagen wieder zu - große Investoren akkumulieren massiv Bitcoin-Wale schlagen wieder zu - große Investoren akkumulieren massiv
ETFs für Senioren: So können auch Rentner vom Kapitalmarkt profitieren ETFs für Senioren: So können auch Rentner vom Kapitalmarkt profitieren
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Scholar Rock Aktie

Kaufen
Verkaufen
Aktien-Sparplan anlegen
36,00 EUR ±0,00 EUR ±0,00 %
BMN
41,47 USD -0,37 USD -0,87 %
BTT
Scholar Rock jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)
Smartphone

Marktkap.3,56 Mrd. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA2JMQW

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS80706P1030

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolSRRK

Scholar Rock Aktien News

DatumMeistgelesen
BenzingaWhy Is Scholar Rock Holding Stock Climbing Today?
BenzingaWhat to Expect from Scholar Rock Holding's Earnings
MotleyFoolWhy Scholar Rock Stock Got Socked on Monday
Wer­bungScholar Rock-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
BenzingaWhy Is Scholar Rock Stock Trading Lower On Monday?
MotleyFoolWhy Scholar Rock Stock Raced 6% Higher Today
BenzingaFirefly Aerospace Posts Q2 Results, Joins Scholar Rock And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
MotleyFoolWhy Scholar Rock Stock Bounced Higher on Monday
BenzingaHow Do Investors Really Feel About Scholar Rock Holding?
BenzingaHere's How Much $1000 Invested In Scholar Rock Holding 5 Years Ago Would Be Worth Today
BenzingaHere's How Much You Would Have Made Owning Scholar Rock Holding Stock In The Last 5 Years
MotleyFoolWhy Scholar Rock Stock Wilted on Wednesday
MotleyFoolScholar Rock (SRRK) Q2 Loss Widens 63%
MotleyFoolWhy Scholar Rock Shares Are Soaring Today
BenzingaA Look Ahead: Scholar Rock Holding's Earnings Forecast
MotleyFoolWhy Scholar Rock Stock Took a Knock on Monday
MotleyFoolWhy Scholar Rock Holding Stock Topped the Market Today
BenzingaScholar Rock Stock Jumps On Additional Data From Pivotal Trial Of Muscular Dystrophy Treatment
BenzingaScholar Rock Sets Sights on $2 Billion Apitegromab Revenue Amid Spinal Muscular Atrophy Market Growth
BusinesswireScholar Rock Highlights 2025 Strategic Priorities
BusinesswireScholar Rock to Present at the 43rd Annual J.P. Morgan Healthcare Conference
BusinesswireScholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BenzingaScholar Rock Stock Jumps As Rival Biohaven's Muscle-Wasting Drug Flunks Pivotal Study
BusinesswireScholar Rock Reports Third Quarter 2024 Financial Results and Highlights Business Progress
BusinesswireScholar Rock Announces New Preclinical Data for SRK-439 Showing Significant Lean Mass Increase and Enhanced Fat Mass Loss with Metformin
BusinesswireScholar Rock to Host Conference Call to Discuss Third Quarter 2024 Financial Results and Provide Business Update on November 12, 2024
BusinesswireScholar Rock to Participate in Upcoming Investor Conferences
BusinesswireScholar Rock to Present New Clinical and Biomarker Data from the Phase 1 DRAGON Trial at the SITC 39th Annual Meeting
BusinesswireScholar Rock Announces Closing of Full Exercise of Option to Purchase Additional Shares in Public Offering
BusinesswireScholar Rock Announces Pricing of Upsized $300 Million Public Offering of Common Stock and Pre-Funded Warrants
BusinesswireScholar Rock Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
BusinesswireScholar Rock Reports Apitegromab Meets Primary Endpoint in Phase 3 SAPPHIRE Study in Patients with Spinal Muscular Atrophy (SMA)
BusinesswireScholar Rock Completes Enrollment in Phase 2 EMBRAZE Proof-of-Concept Trial of Apitegromab in Obesity
BusinesswireScholar Rock Appoints Beth Shafer, Ph.D., to Chief Business Officer
BusinesswireScholar Rock to Participate in Upcoming Investor Conferences
BusinesswireScholar Rock Reports Second Quarter 2024 Financial Results and Highlights Business Progress
BusinesswireScholar Rock to Host Conference Call to Discuss Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024
BusinesswireScholar Rock Announces Initiation of Phase 2 EMBRAZE Trial of Apitegromab in Obesity and New Preclinical Data Supporting SRK-439 in Obesity
BusinesswireScholar Rock to Participate in Upcoming Investor Conferences
BusinesswireScholar Rock to Host Investor Day on May 22, 2024
BusinesswireScholar Rock Reports First Quarter 2024 Financial Results and Highlights Business Progress

Scholar Rock News

Scholar Rock News: auf dieser Seite finden Sie alle Scholar Rock News und Nachrichten zur Scholar Rock Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Scholar Rock News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Scholar Rock News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.